Home Pilots Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation

Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation

February 22, 2022

The system first landed clearance in 2014 for Class III heart failure patients.